T0	Participants 60 73	heart failure
T1	Participants 221 243	chronic heart failure.
T2	Participants 748 814	symptomatic patients with heart failure on optimal medical therapy
T3	Participants 879 929	Up to 650 patients from 80 sites will be recruited
T4	Participants 1025 1209	Inclusion criteria include left ventricular systolic dysfunction, the presence of New York Heart Association Class III symptoms, sinus rhythm, and QRS width less than 120 milliseconds.